Literature DB >> 33068933

Flavanols and triterpenoids from Myrianthus arboreus ameliorate hyperglycaemia in streptozotocin-induced diabetic rats possibly via glucose uptake enhancement and α-amylase inhibition.

Benjamin Kingsley Harley1, Rita Akosua Dickson2, Isaac Kingsley Amponsah2, Inemesit Okon Ben3, Donatus Wewura Adongo3, Theophilus Christian Fleischer4, Solomon Habtemariam5.   

Abstract

Myrianthus arboreus is use traditionally as an antidiabetic agent in Ghana. We reported the in vivo antidiabetic activity of its 70 % ethanol stem bark extract (MAB) which we found to be strongly concentrated in its EtOAc fraction using glucose uptake and enzyme inhibitory assays. The present study sought to investigate the in vivo hypoglycaemic and anti-hyperlipidaemic activity of this ethyl acetate fraction of MAB (MAB-EtOAc, 50 and 100 mg/kg) in streptozotocin (STZ)-induced diabetic rats for 21 days, isolate and evaluate the bioactive constituents responsible for the antidiabetic activity. In silico pharmacokinetic and toxicity properties of the most active compound was also determined. MAB-EtOAc significantly (p < 0.001) reduced the blood glucose levels while normalizing considerably the altered serum lipid parameters of the diabetic rats which was comparable to glibenclamide (5 mg/kg). Chemical investigation of MAB-EtOAc led to the isolation of seven known compounds including three flavanols which are reported for the first time in the plant: epicatechin (1), epigallocatechin (2), dulcisflavan (3), euscaphic acid (4), tormentic acid (5), sitosterol-3-O-β-d-glucopyranoside (6) and arjunolic acid (7). The compounds markedly inhibited the action of α-amylase and, except for 4 and 6, which stimulated considerably glucose uptake in C2C12 cells. Compounds 2, 3, 5, 6 and 7 which were further evaluated in STZ-induced diabetic rats demonstrated hypoglycaemic and anti-hyperlipidaemic activities which, however, were not comparable with MAB-EtOAc. Compound 3, the most active compound was predicted to be non-toxic, non-mutagenic, has reasonable oral bioavailability and a decent substrate for further drug development. The findings of this study show that the isolated compounds may contribute to the antidiabetic activity of M. arboreus and could serve as marker compounds for the quality control of herbal medicines that would be made from the plant.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Antidiabetic; C2C12 myotubes; Flavanols; Glucose uptake; Myrianthus arboreus; α-Amylase

Mesh:

Substances:

Year:  2020        PMID: 33068933     DOI: 10.1016/j.biopha.2020.110847

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  3 in total

1.  Bioactive triterpenoids from Solanum torvum fruits with antifungal, resistance modulatory and anti-biofilm formation activities against fluconazole-resistant candida albicans strains.

Authors:  Benjamin Kingsley Harley; David Neglo; Philip Tawiah; Mercy Adansi Pipim; Nana Ama Mireku-Gyimah; Clement Okraku Tettey; Cedric Dzidzor Amengor; Theophilus Christian Fleischer; Sayanika Devi Waikhom
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.240

2.  Fruits of Vitex doniana sweet: toxicity profile, anti-inflammatory and antioxidant activities, and quantification of one of its bioactive constituents oleanolic acid.

Authors:  Silas Adjei; Isaac Kingsley Amponsah; Samuel Oppong Bekoe; Benjamin Kingsley Harley; Kwesi Boadu Mensah; Abraham Yeboah Mensah; Michael Kwesi Baah; Gabriel Fosu-Mensah
Journal:  Heliyon       Date:  2021-09-02

3.  Ameliorative property of Sesbania grandiflora on carbohydrate metabolic enzymes in the liver and kidney of streptozotocin-induced diabetic rats.

Authors:  Chandrabose Sureka; Veerayan Elango; Sameer Al-Ghamdi; Khaled K Aldossari; Mohammed Alsaidan; Ayman Geddawy; Mohamed A Abdelaziz; Abubucker Peer Mohideen; Thiyagarajan Ramesh
Journal:  Saudi J Biol Sci       Date:  2021-05-08       Impact factor: 4.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.